ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society

WRITING COMMITTEE MEMBERS, Hunt, Sharon Ann, Abraham, William T., Chin, Marshall H., Feldman, Arthur M., Francis, Gary S., Ganiats, Theodore G., Jessup, Mariell +22 more·2005·Circulation
DOI 10.1161/circulationaha.105.167586

Cites (789)

Items 401–600 of 788

  1. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients.
    Sylvia M. Dobbs, W I Kenyon, R. John Dobbs · 1977 · BMJ
  2. Left Ventricular Structure and Function in Children Infected With Human Immunodeficiency Virus
    Steven E. Lipshultz, Kirk A. Easley, Endel John Orav, Samuel Kaplan, Thomas J. Starc, J. Timothy Bricker, Wyman W. Lai, Douglas S. Moodie, Kenneth McIntosh, MARK D. SCHLUCHTER et al. · 1998 · Circulation
  3. Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added beta adrenergic blocking agent
    Daniel David, Elio Di Segni, Herman O. Klein, Elieser Kaplinsky · 1979 · The American Journal of Cardiology
  4. Diabetes mellitus and congestive heart failure
    L SOLANG · 1999 · European Heart Journal
  5. The expanding national burden of heart failure in the United States: the influence of heart failure in women
    Todd M. Koelling, Roland S. Chen, ROBERT N. LUBWAMA, Gilbert J L'Italien, Kim Allen Eagle · 2003 · American Heart Journal
  6. Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy.
    Jay W. Mason, Michael R. Bristow, Margaret E. Billingham, John R. Daniels · 1978 · PubMed
  7. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: A multicenter, 12-month follow-up study of patients with chronic heart failure
    Anthony Magalski, Philip B. Adamson, Frederick Gadler, Michael Böehm, David M. Steinhaus, DWIGHT W. REYNOLDS, Kathryn Vlach, Cecilia Marianne Linde, Bodo Cremers, Brandon S. Sparks et al. · 2002 · Journal of Cardiac Failure
  8. Sodium and water balance in chronic congestive heart failure.
    Robert J Cody, Andrew B. Covit, Gary L. Schaer, JOHN H. LARAGH, Jean E. Sealey, Joseph Feldschuh · 1986 · Journal of Clinical Investigation
  9. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure
    Barry M. Masse, Kanu Chatterjee, Jeffrey A. Werner, Barry Greenberg, Richard Hart, William W. Parmley · 1977 · The American Journal of Cardiology
  10. Improvement Following Correction of Secondary Mitral Regurgitation in End-Stage Cardiomyopathy With Mitral Annuloplasty
    David S. Bach, Steven F. Bolling · 1996 · The American Journal of Cardiology
  11. Double-Blind Placebo-Controlled Study of Ibopamine and Diagoxin in Patients With Mild to Moderate Heart Failure: Results of the Dutch of the Ibopamine Multicenter Trial (DIMT)
    Dirk Jan van Veldhuisen, Arie J. Man in’t Veld, Peter H.J.M. Dunselman, Dirk J. A. Lok, Henk J. M. Dohmen, J.Cees Poortermans, Adrie J.A.M. Withagen, W. Hans Pasteuning, Jan Brouwer, Kong Ing Lie · 1993 · Journal of the American College of Cardiology
  12. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure
    Claes Hofman‐Bang, Nina Rehnqvist, Karl B Swedberg, Ingela E Wiklund, Hans Åström · 1995 · Journal of Cardiac Failure
  13. The Dor procedure: What has changed after fifteen years of clinical practice?
    Lorenzo Menicanti, Marisa Di Donato · 2002 · Journal of Thoracic and Cardiovascular Surgery
  14. Principles of educational outreach ('academic detailing') to improve clinical decision making
    Stephen B. Soumerai · 1990 · JAMA
  15. Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria
    Vaur, Laurent, Gueret, Pascal, Lievre, Michel, Chabaud, Sylvie, Passa, Philippe, For the DIABHYCAR Study Group · 2003 · Diabetes Care
  16. Changes in Quality of Care for Five Diseases Measured by Implicit Review, 1981 to 1986
    Lisa V. Rubenstein · 1990 · JAMA
  17. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm
    Kevin G. Peters, Michael G. Kienzle · 1988 · The American Journal of Medicine
  18. Coronary vasoconstriction and catecholamine cardiomyopathy
    Michael Simons, Sarah E. Downing · 1985 · American Heart Journal
  19. Quality of Care for Elderly Patients Hospitalized With Heart Failure
    Harlan M. Krumholz · 1997 · Archives of Internal Medicine
  20. Improvement in Exercise Tolerance and Symptoms of Congestive Heart Failure During Treatment With Candesartan Cilexetil
    Günter A.J. Riegger, H Bouzo, P. Petr, J. Münz, Radim Špaček, H. Pethig, V von Behren, M. George, H.-J. Arens · 1999 · Circulation
  21. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group · 2003 · ACC Current Journal Review
  22. Clinical benefits of low serum digoxin concentrations in heart failure
    Kirkwood F. Adams, Mihai Gheorghiade, Barry F. Uretsky, James Herbert Patterson, Todd A. Schwartz, James B. Young · 2002 · Journal of the American College of Cardiology
  23. Bradykinin Antagonism Inhibits the Antigrowth Effect of Converting Enzyme Inhibition in the Dog Myocardium After Discrete Transmural Myocardial Necrosis
    Kenneth McDonald, James Mock, Antonio D’Aloia, Todd B. Parrish, Kate Hauer, Gary S. Francis, Arthur E. Stillman, Jay N. Cohn · 1995 · Circulation
  24. B-type natriuretic peptide levels: A potential novel “white count” for congestive heart failure
    Alan Maisel · 2001 · Journal of Cardiac Failure
  25. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)
    John B. Kostis, Brent J. Shelton, Gilbert Gosselin, Claude Goulet, William B. Hood, Robert M. Kohn, Spencer H. Kubo, ELEANOR B. SCHRON, Melvin B. Weiss, Park W. Willis et al. · 1996 · American Heart Journal
  26. Life-Threatening Interaction of Mibefradil and β-Blockers With Dihydropyridine Calcium Channel Blockers
    Michael Eugene Mullins · 1998 · JAMA
  27. National Patterns of Angiotensin-Converting Enzyme Inhibitor Use in Congestive Heart Failure
    Stafford, Randall S. · 1997 · Archives of Internal Medicine
  28. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study
    Jay N. Cohn, Debbie Archibald, Susan Ziesche, Joseph A. Franciosa, William E. Harston, Felix E. Tristani, W. Bruce Dunkman, William S. Jacobs, Gary S. Francis, Kathleen H. Flohr et al. · 1987 · Survey of Anesthesiology
  29. Trastuzumab in the Treatment of Metastatic Breast Cancer
    Arthur Michael Feldman, Beverly H. Lorell, Steven E. Reís · 2000 · Circulation
  30. Usefulness of Taurine in Chronic Congestive Heart Failure and Its Prospective Application.
    Junichi Azuma, Akihiko Sawamura, Nobuhisa Awata · 1992 · Japanese Circulation Journal-english Edition
  31. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The dual chamber and VVI implantable defibrillator (DAVID) trial
    The DAVID Trial Investigators · 2003 · ACC Current Journal Review
  32. Effect of diuresis on the performance of the failing left ventricle in man
    John R. Wilson, Nathaniel Reichek, W. Bruce Dunkman, Sheldon Goldberg · 1981 · The American Journal of Medicine
  33. The Serum Digitalis Concentration — Does It Diagnose Digitalis Toxicity?
    Joseph A. Ingelfinger, Peter Goldman · 1976 · New England Journal of Medicine
  34. Cost-effectiveness Analysis in Clinical Practice
    Michael W. Rich, Robert F. Nease · 1999 · Archives of Internal Medicine
  35. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting enzyme inhibitors: the CHARM-alternative trial
    Christopher Bull Granger, John J.V. McMurray, Salim Yusuf · 2004 · ACC Current Journal Review
  36. Treatment of congestive heart failure with coenzyme Q10 Illuminated by meta-analyses of clinical trials
    Anne Merete Boas Soja, Svend Aage Mortensen · 1997 · Molecular Aspects of Medicine
  37. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure
    Duilio Pagano, Robert Stuart Bonser, John Townend, Farzin Fath‐Ordoubadi, Roberto Lorenzoni, Paolo Guido Camici · 1998 · Heart
  38. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.
    Kam Sang Woo, M. Gary Nicholls · 1995 · PubMed
  39. A nomogram for digoxin therapy
    Roger W. Jelliffe, Gary Brooker · 1974 · The American Journal of Medicine
  40. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure11Coenzyme Q and matching placebo tablets were supplied by Health World Limited, Brisbane, Australia.
    Paul S. Watson, Gregory Michael Scalia, Andrew J. Galbraith, Darryl John Burstow, Nicholas Bett, Constantine N Aroney · 1999 · Journal of the American College of Cardiology
  41. Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.
    Craig M. Pratt, A. John Camm, William Cooper, Peter L. Friedman, Daniel J. MacNeil, Kathleen M. Moulton, Bertram Pitt, Peter J. Schwartz, Enrico P. Veltri, Albert L. Waldo · 1998 · The American Journal of Cardiology
  42. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease
    Wilbert S. Aronow, Chul Woo Ahn, Itzhak Kronzon · 1990 · The American Journal of Cardiology
  43. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial
    The AF-CHF Trial Investigators · 2002 · American Heart Journal
  44. Gender Differences in 1-Year Survival and Quality of Life Among Patients Admitted With Congestive Heart Failure
    Marshall H. Chin, Lee Goldman · 1998 · Medical Care
  45. Detection of anthracycline-induced cardiotoxicity
    Martin T. Meinardi, Winette T.A. van der Graaf, Dirk J van Veldhuisen, Jourik A. Gietema, Elisabeth G.E. de Vries, Dirk Th. Sleijfer · 1999 · Cancer Treatment Reviews
  46. Comprehensive multidisciplinary programs for the management of patients with congestive heart failure
    Edward F. Philbin · 1999 · Journal of General Internal Medicine
  47. Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy.
    Eva Steiness, Knud Henning Olesen · 1976 · Heart
  48. Atrial Fibrillation in Heart Failure
    William G. Stevenson, Lynne Warner Stevenson · 1999 · New England Journal of Medicine
  49. The progression from hypertension to congestive heart failure
    1997 · ACC Current Journal Review
  50. Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial.
    Barry Greenberg, Barry M. Massie, James D Bristow, M.D. Cheitlin, Deirdre Siemienczuk, Nina Topic, R A Wilson, Jadwiga Szlachcic, D Thomas · 1988 · Circulation
  51. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure
    Gogia, Harinder, Mehra, Anilkumar, Parikh, Sunita, Raman, Murli, Ajit-Uppal, Jasvir, Johnson, Janet V., Elkayam, Uri · 1995 · Journal of the American College of Cardiology
  52. Combined Oral Hydralazine-Nitrate Therapy in Left Ventricular Failure
    Gordon L. Pierpont, Jay N. Cohn, Joseph A. Franciosa · 1978 · CHEST Journal
  53. Cardiac Dysfunction Occurs in the HIV-1 Transgenic Mouse Treated with Zidovudine
    William Lewis, Ingrid L. Grupp, Günter Grupp, Brian D. Hoit, Randal Morris, Allen Mark Samarel, Leslie A. Bruggeman, Paul E. Klotman · 2000 · Laboratory Investigation
  54. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
    1993 · Journal of Cardiothoracic and Vascular Anesthesia
  55. Passive epicardial containment prevents ventricular remodeling in heart failure
    Pervaiz A. Chaudhry, Takayuki Mishima, Victor G. Sharov, James E Hawkins, Clif A. Alferness, Gaetano Paone, Hani N. Sabbah · 2000 · The Annals of Thoracic Surgery
  56. β2-Adrenergic Receptor Antagonists Protect Against Ventricular Fibrillation
    George E. Billman, Lourdes Castillo, James Hensley, Charlene M. Hohl, Ruth A. Altschuld · 1997 · Circulation
  57. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure.
    Milton Packer · 1992 · PubMed
  58. Diastolic dysfunction as a cause of heart failure
    Litwin, Sheldon E., Grossman, William · 1993 · Journal of the American College of Cardiology
  59. Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure.
    Kazuo Komamura, Richard P. Shannon, Ares D. Pasipoularides, Tadashi Ihara, Alan S. Lader, Thomas A. Patrick, Sanford P. Bishop, Stephen F. Vatner · 1992 · Journal of Clinical Investigation
  60. Heart failure with normal systolic function. Update of prevalence, differential diagnosis, prognosis, and therapy
    Kenneth M. Kessler · 1988 · Archives of Internal Medicine
  61. The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research
    Masoudi, Frederick A., Havranek, Edward P., Krumholz, Harlan M. · 2002 · Heart Failure Reviews
  62. Does Digoxin Provide Additional Hemodynamic and Autonomic Benefit at Higher Doses in Patients With Mild to Moderate Heart Failure and Normal Sinus Rhythm?
    Monte L. Slatton, Waleed N. Irani, SHELLEY A. HALL, Lucille Marcoux, Richard L. Page, Paul Arthur Grayburn, Eric J. Eichhorn · 1997 · Journal of the American College of Cardiology
  63. Dexrazoxane
    Lynda R. Wiseman, Caroline M. Spencer · 1998 · Drugs
  64. Prognostic factors for atherosclerosis progression in saphenous vein grafts
    MICHAEL J. DOMANSKI, Craig B. Borkowf, LUCIEN A. CAMPEAU, Genell L. Knatterud, Carl W. White, Byron J. Hoogwerf, Yves Rosenberg, Nancy L. Geller · 2000 · Journal of the American College of Cardiology
  65. Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.
    Alison Cowley, Allan M. Skene · 1994 · Heart
  66. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
    Milton Packer, Norma Medina, Madeline Yushak, Jose Meller · 1983 · Circulation
  67. Congestive Heart Failure With Normal Left Ventricular Systolic Function
    Ramachandran Srini Vasan · 1996 · Archives of Internal Medicine
  68. Angiotensin II Receptor Blockers in Patients with ACE Inhibitor–Induced Angioedema
    Kelly K Warner, James A. Visconti, Marva M. Tschampel · 2000 · Annals of Pharmacotherapy
  69. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure
    E. Baggio, Renato Gandini, Angelo Cesare Plancher, M Passeri, G Carmosino · 1994 · Molecular Aspects of Medicine
  70. Furosemide in patients with heart failure: Shift in dose-response curves
    D. Craig Brater, Polavat Chennavasin, Ruth Seiwell · 1980 · Clinical Pharmacology & Therapeutics
  71. The Effect of Beta Adrenergic Blockade on Patterns of Urinary Sodium Excretion
    Stephen E. Epstein, Eugene Braunwald M. D · 1966 · Annals of Internal Medicine
  72. Disparities in Trends of Hospitalization for Potentially Preventable Chronic Conditions Among African Americans During the 1990s: Implications and Benchmarks
    Sharon Davis, Yong Liu, Gary H. Gibbons · 2003 · American Journal of Public Health
  73. Radiographic pulmonary congestion in end-stage congestive heart failure
    Hooman Mahdyoon, Roger Klein, William R. Eyler, Jeffrey B. Lakier, Simon C. Chakko, Mihai Gheorghiade · 1989 · The American Journal of Cardiology
  74. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure1
    James F. McCarthy, Patrick M. McCarthy, Randall C. Starling, Nicholas Gerard Smedira, Gregory Michael Scalia, James Wong, Vigneshwar Kasirajan, Marlene Goormastic, James B. Young · 1998 · European Journal of Cardio-Thoracic Surgery
  75. Resource Use and Survival of Patients Hospitalized with Congestive Heart Failure: Differences in Care by Specialty of the Attending Physician
    Andrew David Auerbach, Mary Beth Hamel, Roger B. Davis, Alfred F. Connors, Carol R. Regueiro, Norman A. Desbiens, Lee Goldman, Robert M. Califf, Neal V. Dawson, Neil S. Wenger et al. · 2000 · Annals of Internal Medicine
  76. Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure
    Thomas D. Giles, Richard J. Katz, Jay M. Sullivan, Paul Wolfson, Mark Haugland, Philip C. Kirlin, Eric R. Powers, Stuart Rich, Barry T. Hackshaw, Anthony J. Chiaramida et al. · 1989 · Journal of the American College of Cardiology
  77. SLEEP APNEA IN CONGESTIVE HEART FAILURE
    Matthew T. Naughton, Thomas Douglas Bradley · 1998 · Clinics in Chest Medicine
  78. Pathogenesis of HIV-associated cardiovascular complications
    Giuseppe Bárbaro, Stacy D. Fisher, Steven E. Lipshultz · 2001 · The Lancet Infectious Diseases
  79. Combined Therapy with Thiazide-Type and Loop Diuretic Agents for Resistant Sodium Retention
    James R. Oster, MURRAY EPSTEIN, SCOTT SMOLLER · 1983 · Annals of Internal Medicine
  80. Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure
    Marshall H. Chin, Peter D. Friedmann, Christine K. Cassel, Roberto Miguel Lang · 1997 · Journal of General Internal Medicine
  81. Effects of Increasing Maintenance Dose of Digoxin on Left Ventricular Function and Neurohormones in Patients With Chronic Heart Failure Treated With Diuretics and Angiotensin-Converting Enzyme Inhibitors
    Mihai Gheorghiade, Veronica B. Hall, Gordon Jacobsen, Mohsin Alam, Howard Rosman, Sidney Goldstein · 1995 · Circulation
  82. Parenteral inotropic support for advancedcongestive heart failure
    Carl V. Leier, P BINKLEY · 1998 · Progress in Cardiovascular Diseases
  83. Epinephrine-induced hypokalemia: The role of beta adrenoceptors
    John L. Reid, Kenneth F. Whyte, Allan D. Struthers · 1986 · The American Journal of Cardiology
  84. Classifying general medicine readmissions
    E.Z. Oddone, Morris Weinberger, M. Horner, C. Mengel, F. Goldstein, Paulette Ginier, Dean G. Smith, J. Huey, N J Farber, David A. Asch et al. · 1996 · Journal of General Internal Medicine
  85. How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
    Morten Svensson, Finn Gustafsson, Søren Galatius, Per Rossen Hildebrandt, Dan Atar · 2004 · Journal of Cardiac Failure
  86. Oxy free radical system in heart failure and therapeutic role of oral vitamin E
    Ashim Ghatak, Mohan Jeet Singh Brar, Ajay Kumar Agarwal, N Goel, Anil K. Rastogi, Arvind Kumar Vaish, Amulya Ranjan Sircar, Mahesh Chandra · 1996 · International Journal of Cardiology
  87. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure
    Gad Cotter, Jeoshua Weissgarten, Einat Metzkor, Yaron Moshkovitz, I Litinsky, Uri Tavori, Chava Perry, Ronit Zaidenstein, Ahuva Golik · 1997 · Clinical Pharmacology & Therapeutics
  88. Oral amrinone for the treatment of chronic congestive heart failure: Results of a multicenter randomized double-blind and placebo-controlled withdrawal study
    Robert DiBianco, Ralph W. Shabetai, Barry D. Silverman, Carl V. Leier, Joseph R. Benotti · 1984 · Journal of the American College of Cardiology
  89. Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches
    Kelly LR Miller, Richard S. Liebowitz, Laura Kristin Newby · 2004 · American Heart Journal
  90. Diuretic Combinations in Refractory Oedema States
    Domenic A. Sica, Todd W.B. Gehr · 1996 · Clinical Pharmacokinetics
  91. Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy.
    Milton Packer · 1990 · Circulation
  92. Metabolic Syndrome Epidemic
    Dean J. Kereiakes, James T. Willerson · 2003 · Circulation
  93. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
    John Anthony Bauer, H L Fung · 1991 · Circulation
  94. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure
    Milton Packer, Norma Medina, Madeline Yushak · 1984 · Journal of the American College of Cardiology
  95. The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: A dangerous imbalance in the risk-benefit ratio
    Craig M. Pratt, Terry Eaton, Marilyn J. Francis, Sam Woolbert, John J. Mahmarian, Robert Roberts, James B. Young · 1989 · American Heart Journal
  96. Acute Hemodynamic Interaction of Aspirin and Ticlopidine With Enalapril
    Christian M. Spaulding, B Charbonnier, Alain Cohen Solal, Yves Juillière, Eckhard P. Kromer, Khaldoun Ben-Hamda, Romain Cador, Simon Weber · 1998 · Circulation
  97. Favorable left ventricular remodeling following large myocardial infarction by exercise training. Effect on ventricular morphology and gene expression.
    T L Orenstein, Thomas G. Parker, JAGDISH W. BUTANY, Jack M. Goodman, Fayez Dawood, Wen Wang, Lily Wee, Tami A. Martino, Peter R. McLaughlin, P P Liu · 1995 · Journal of Clinical Investigation
  98. Intermediate Survival and Predictors of Death After Surgical Ventricular Restoration
    Marisa Di Donato, Anna Toso, Mauro Maioli, Michel Sabatier, Alfred W.H. Stanley, Vincent Dor · 2001 · Seminars in Thoracic and Cardiovascular Surgery
  99. Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.
    Barry M. Massie, B Krämer, Nina Topic · 1984 · Circulation
  100. Dilated Cardiomyopathy in HIV-Infected Patients
    Steven E. Lipshultz · 1998 · New England Journal of Medicine
  101. Living with and dying from heart failure: the role of palliative care
    J. Simon R. Gibbs, Anne S.M. McCoy, Louise Gibbs, Angie Rogers, Julia M Addington-Hall · 2002 · Heart
  102. Aldosterone in Congestive Heart Failure: Analysis of Determinants and Role in Sodium Retention
    Johannes Hensen, William T. Abraham, Jacques A. Dürr, Robert W. Schrier · 2008 · American Journal of Nephrology
  103. Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
    J Bayliss, M S Norell, Rudolph Canepa-Anson, C. Reid, Philip Alexander Poole-Wilson, George C. Sutton · 1985 · BMJ
  104. Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.
    Piergiuseppe Agostoni, Nicoletta De Cesare, E Doria, Alvise Polese, Gloria Tamborini, Marco Guazzi · 1986 · Heart
  105. Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure
    Joseph L. Izzo, Alan H. Gradman · 2004 · Medical Clinics of North America
  106. Plasma Volume Expansion Resulting from Interference with Adrenergic Function in Normal Man
    John V. Weil, Charles A. Chidsey · 1968 · Circulation
  107. Effects of exercise training and activity restriction on 6-minute walking test performance in patients with chronic heart failure
    Katharina Meyer, Matthias Schwaibolda, Samuel Westbrook, Ralph Beneke, Ramiz Hajrić, Manfred J. Lehmann, H. Roskamm · 1997 · American Heart Journal
  108. Aldosterone and antialdosterone therapy in congestive heart failure
    Karl T. Weber, Daniel Villarreal · 1993 · The American Journal of Cardiology
  109. Optimizing therapy for complex or refractory heart failure: A management algorithm
    Lynne Warner Stevenson, Barry M. Massie, Gary S. Francis · 1998 · American Heart Journal
  110. Variable Furosemide Absorption and Poor Predictability of Response in Elderly Patients
    Michael D. Murray, Kathy M. Haag, Paula Black, Stephen David Hall, D. Craig Brater · 1997 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  111. Cardiology or Primary Care for Heart Failure in the Community Setting
    Edward F. Philbin, Henry Weil, Tara A. Erb, Paul Jenkins · 1999 · CHEST Journal
  112. Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog.
    Kenneth McDonald, Michael D. Garr, Peter F. Carlyle, Gary S. Francis, Katherine M. Hauer, David W. Hunter, Tracie R. Parish, Arthur E. Stillman, Jay N. Cohn · 1994 · Circulation
  113. Effect of Mibefradil, a T-Type Calcium Channel Blocker, on Morbidity and Mortality in Moderate to Severe Congestive Heart Failure
    T. Barry Levine, Peter J. L. M. Bernink, Abraham Caspi, Uri Elkayam, Edward M. Geltman, Barry Greenberg, William John McKenna, Jalal K. Ghali, Thomas D. Giles, Alon T Marmor et al. · 2000 · Circulation
  114. Systemic thromboembolism in chronic heart failure: A prospective study in 406 patients
    Giovanni Cioffi, Massimo Pozzoli, G. Forni, Mariella Franchini, Cristina Opasich, Franco Cobelli, Luigi Tavazzi, with the technical assistance of D. Rossi · 1996 · European Heart Journal
  115. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic ana nonischemic cardiomyopathy
    Michael Evan Silverman, Michael D. Pressel, Jeffrey C. Brackett, Salvatore Lauria, Michael Robert Gold, Stephen S. Gottlieb · 1995 · The American Journal of Cardiology
  116. Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients
    Karel Pardaens, Johan Van Cleemput, Johan Vanhaecke, Robert H. Fagard · 1997 · Heart
  117. Congestive heart failure in patients with coronary artery disease: The gender paradox
    Lisa A. Mendes, Ravin Davidoff, L. Adrienne Cupples, Thomas J. Ryan, Alice K. Jacobs · 1997 · American Heart Journal
  118. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.
    Milton Packer, W H Lee, Paul D. Kessler · 1986 · Circulation
  119. Selection of patients for heart transplantationin the current era of heart failure therapy
    Javed Butler, Ghazanfar Khadim, Kimberly M. Paul, Stacy F. Davis, Marvin W. Kronenberg, Don B. Chomsky, Richard N. Pierson, John R. Wilson · 2004 · Journal of the American College of Cardiology
  120. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    John Adams Jarcho, David C. Naftel, TERRIE W. SHROYER, James K. Kirklin, Robert C. Bourge, Mark L. Barr, Douglas E. Pitts, R.C. Starling · 1994 · PubMed
  121. Management of Heart Failure
    David W. Baker · 1994 · JAMA
  122. Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure
    Andrew B. Covit, Gary L. Schaer, Jean E. Sealey, John H. Laragh, Robert J Cody · 1983 · The American Journal of Medicine
  123. Intermittent inotropic therapy in an outpatient setting: A cost-effective therapeutic modality in patients with refractory heart failure
    Andres L. Marius-Nunez, Lori Heaney, Raymond N. Fernandez, William Andrew Clark, Anil Ranganini, Earl N. Silber, Pablo Denes · 1996 · American Heart Journal
  124. FALLIBILITY OF PLASMA-DIGOXIN IN DIFFERENTIATING TOXIC FROM NON-TOXIC PATIENTS
    Alan M. Fogelman, Simon Finkelstein, J. Thomas LaMont, E. Rado, Morton Lee Pearce · 1971 · The Lancet
  125. Prolonged bed rest in the treatment of idiopathic cardiomyopathy
    C.D. McDonald, G.E. Burch, John James Walsh · 1972 · The American Journal of Medicine
  126. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure
    Uri Elkayam, Mohammed Waseem Akhter, Harpreet Singh, Salman Ali Khan, Ahsan Usman · 2004 · The American Journal of Cardiology
  127. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure
    Uri Elkayam, Laura Weber, Charles R. McKay, Shahbudin H. Rahimtoola · 1985 · The American Journal of Cardiology
  128. Cardiac toxicity of trastuzumab (Herceptin): Implications for the design of adjuvant trials
    J. A. Sparano · 2001 · Seminars in Oncology
  129. Prevention of heart failure
    David W. Baker · 2002 · Journal of Cardiac Failure
  130. Right and left ventricular diastolic function in patients with and without heart failure: Effect of age, sex, heart rate, and respiration on Doppler-derived measurements
    Cheuk‐Man Yu, John Elsby Sanderson · 1997 · American Heart Journal
  131. Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency
    Robert K. Rude · 1989 · The American Journal of Cardiology
  132. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawl in chronic heart failure: A double-blind, placebo-controlled study of quinapril
    Peter W. Pflugfelder, G. Baird, Melvin J. Tonkon, Robert DiBianco, Bertram Pitt · 1993 · Journal of the American College of Cardiology
  133. Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure
    J.N. Barjon, Jean Lucien Rouleau, Daniel Georges Bichet, Carl Juneau, Jacques de Champlain · 1987 · Journal of the American College of Cardiology
  134. Placebo-Controlled Study of Lisinopril in Congestive Heart Failure
    John Philip Chalmers, Malcolm West, Joachim Cyran, D. De La Torre, Marc Englert, Marija Kramar, G. R. J. Lewis, M. F. L. Maranhao, D.P. Myburgh, Peter Moritz Schuster et al. · 1987 · Journal of Cardiovascular Pharmacology
  135. Valsartan in heart failure patients previously untreated with an ACE inhibitor
    Vladimir P. Mazaev, И. Г. Фомина, Э. Н. Казаков, Vitaly A. Sulimov, T.V Zvereva, Люсов Виктор Алексеевич, Valery A. Orlov, L. I. Olbinskaya, Т Д Большакова, J Sullivan et al. · 1998 · International Journal of Cardiology
  136. Cardiovascular sequelae of therapeutic thoracic radiation
    Michael A. Arsenian · 1991 · Progress in Cardiovascular Diseases
  137. Digitalis Therapy for Patients in Clinical Heart Failure
    Shahbudin H. Rahimtoola · 2004 · Circulation
  138. The Public Release of Performance Data: What Do We Expect to Gain? A Review of the Evidence
    &NA; · 2001 · Survey of Anesthesiology
  139. Oral Torsemide in Patients With Chronic Congestive Heart Failure: Effects on Body Weight, Edema, and Electrolyte Excretion
    James Herbert Patterson, Kirkwood F. Adams, Mark M. Applefeld, Clinton N. Corder, Benoît R. Mâsse, The Torsemide Investigators Group · 1994 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  140. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension
    Miguel M. Iriarte, Nekane Murga, José Domingo Sagastagoitia, Enrique Molinero, Miren Morillas, Alberto Salcedo, Pedro Estella, Jon Etxebeste · 1993 · The American Journal of Cardiology
  141. Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure
    Jalal K. Ghali, Sunil Kadakia, Richard Cooper, Youlian Liao · 1991 · The American Journal of Cardiology
  142. Safety of ephedra: lessons learned
    Madhusudan G. Soni, Ioana G. Carabin, James C. Griffiths, George A. Burdock · 2004 · Toxicology Letters
  143. Exercise training and plasma catecholamines in patients with ischemic heart disease
    Cooksey, Jon D., Reilly, Patricia, Brown, Sandra, Bomze, Howard, Cryer, Philip E. · 1978 · The American Journal of Cardiology
  144. Fate of left ventricular thrombi in patients with remote myocardial infarction or idiopathic cardiomyopathy.
    J R Stratton, John W. Nemanich, Karl-Arne Johannessen, A D Resnick · 1988 · Circulation
  145. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure
    Leif Erhardt, Anne MacLean, John P. Ilgenfritz, Kate Gelperin, Mel Blumenthal, FOR THE FOSINOPRIL EFFICACY/SAFETY TRIAL (FEST) STUDY GROUP · 1995 · European Heart Journal
  146. The Care of Dying Patients: A Position Statement from the American Geriatrics Society
    1995 · Journal of the American Geriatrics Society
  147. Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure
    Divakar Sharma, Marc E Buyse, Bertram Pitt, Ewa J. Rucinska · 2000 · The American Journal of Cardiology
  148. Effect of prolonged nitrate therapy on left ventricular remodeling after canine acute myocardial infarction.
    Bodh I. Jugdutt, Michael Khan · 1994 · Circulation
  149. Myocarditis and Endomyocardial Biopsy in Unexplained Heart Failure: A Diagnosis in Search of a Disease
    J T Lie · 1988 · Annals of Internal Medicine
  150. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: Results of a multicenter study in the United States
    Jeffrey L. Anderson · 1991 · American Heart Journal
  151. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.
    William A. Littler, Desmond John Sheridan · 1995 · Heart
  152. Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure
    Milton Packer, Wai Hung Lee, Paul Kessler, Norma Medina, Madeline Yushak, Stephen S. Gottlieb · 1987 · Journal of the American College of Cardiology
  153. Clinical Perspectives
    Massimo Francesco Piepoli, MD Flather, Andrew J.S. Coats · 1998 · European Heart Journal
  154. Clinical outcomes in heart failure: report from a community hospital-based registry
    Edward F. Philbin, Thomas A. Rocco, Norman W Lindenmuth, Kathleen Ulrich, Paul Jenkins · 1999 · The American Journal of Medicine
  155. Toleration of High Doses of Angiotensin-Converting Enzyme Inhibitors in Patients With Chronic Heart Failure
    Barry M. Massie, Paul W. Armstrong, John G.F. Cleland, John David Horowitz, Milton Packer, Philip Alexander Poole-Wilson, Lars Rydén · 2001 · Archives of Internal Medicine
  156. LISTING CRITERIA FOR CARDIAC TRANSPLANTATION
    Leslie W. Miller · 1998 · Transplantation
  157. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction. The framingham heart study
    Ramachandran Srini Vasan, Emelia J. Benjamin, Martin G. Larson · 2003 · ACC Current Journal Review
  158. Thiazolidinediones for type 2 diabetes
    Andrew J. Krentz · 2000 · BMJ
  159. Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates.
    Mauro Pepi, Giancarlo Marenzi, Piergiuseppe Agostoni, E Doria, Paolo Barbier, Manuela Muratori, Fabrizio Celeste, Marco Guazzi · 1993 · Heart
  160. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: Clinical experience in 21 patients
    Mark M. Applefeld, Kathryn A. Newman, Frederick J. Sutton, William P. Reed, David S. Roffman, Barry S. Talesnick, William R. Grove · 1987 · American Heart Journal
  161. Sympatholytic Action of Intravenous Amiodarone in the Rat Heart
    Xiao‐Jun Du, Murray Esler, Anthony Michael Dart · 1995 · Circulation
  162. Effect of Antithrombotic Therapy on Risk of Sudden Coronary Death in Patients With Congestive Heart Failure
    Daniel L. Dries, MICHAEL J. DOMANSKI, Myron A. Waclawiw, Bernard John Gersh · 1997 · The American Journal of Cardiology
  163. Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure
    Gattis, Wendy A, O’Connor, Christopher M, Leimberger, Jeffrey D, Felker, G.Michael, Adams, Kirkwood F, Gheorghiade, Mihai · 2003 · The American Journal of Cardiology
  164. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: A randomized, double-blind, placebo-controlled study
    Avishay Elis, Tamir Bental, Oded Kimchi, Mordchai Ravid, Michael Lishner · 1998 · Clinical Pharmacology & Therapeutics
  165. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: Safety and cost efficacy
    Andrew Paul Sindone, ANNE M. KEOGH, Peter Simon Macdonald, Cate McCosker, Anne Marie Kaan · 1997 · American Heart Journal
  166. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: A preliminary study
    David A. Cesario, Julie Clark, Alan Maisel · 1998 · American Heart Journal
  167. Mechanisms, diagnosis, and treatment of diastolic heart failure
    Daniel John Lenihan, Myron Craig Gerson, Brian D. Hoit, Richard A. Walsh · 1995 · American Heart Journal
  168. Quabain: Temporal relationship between the inotropic effect and the in vitro binding to, and dissociation from, (Na++K+)-activated ATPase
    Tai Akera, S. I. Baskin, Thomas J. Tobin, Thomas Brody · 1973 · Naunyn-Schmiedeberg s Archives of Pharmacology
  169. Exercise Testing in the Evaluation of the Patient with Chronic Cardiac Failure
    Karl T. Weber, John R. Wilson, Joseph S. Janicki, Mariell Jessup Likoff · 1984 · American Review of Respiratory Disease
  170. Diuretic Treatment for the Sodium Retention of Congestive Heart Failure
    Robert J Cody · 1994 · Archives of Internal Medicine
  171. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.
    Keith T. Weber, V Andrews, Joseph S. Janicki, Mariell Jessup Likoff, Nathaniel Reichek · 1982 · Circulation
  172. Managed Care and Outcomes of Hospitalization Among Elderly Patients With Congestive Heart Failure
    Hanyu Ni, Deirdre J. Nauman, Ray E. Hershberger · 1998 · Archives of Internal Medicine
  173. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.
    Milton Packer, P D Kessler, W H Lee · 1987 · PubMed
  174. Comparison of the Effects of AV Nodal Ablation Versus AV Nodal Modification in Patients with Congestive Heart Failure and Uncontrolled Atrial Fibrillation
    Nicholas Twidale, TOM MCDONALD, Kelly Nave, Audrey Seal · 1998 · Pacing and Clinical Electrophysiology
  175. Endomyocardial Biopsy in Patients with Unexplained Congestive Heart Failure
    Leon C. Chow, Howard C. Dittrich, Ralph Shabetai · 1988 · Annals of Internal Medicine
  176. CONGESTIVE HEART FAILURE IN OLDER PATIENTS: The Clinical Diagnosis of Heart Failure in Older Patients*
    Donald D. Tresch · 1997 · Journal of the American Geriatrics Society
  177. Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Organic Nitrates in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibition
    Uri Elkayam, Janet V. Johnson, Avraham Shotan, Syed Rizwan A. Bokhari, Alejandro Solodky, Menahem Canetti, Omar Rashid Wani, Ilyas Somer Karaalp · 1999 · Circulation
  178. Management of atrial fibrillation in the setting of heart failure
    Harry J.G.M. Crijns, Maarten P. van den Berg, Isabelle C. Van Gelder, Dirk Jan van Veldhuisen · 1997 · European Heart Journal
  179. Effect of intermittent left bundle branch block on left ventricular performance
    Akira Takeshita, Lotfy L. Basta, J. Michael Kioschos · 1974 · The American Journal of Medicine
  180. The Risk of Hospitalization for Congestive Heart Failure Among Older Adults
    Fredric D. Wolinsky, J. Marc Overhage, Timothy E. Stump, Robert M. Lubitz, David M. Smith · 1997 · Medical Care
  181. Hypercoagulability in Heart Failure
    Syed M. Jafri · 1997 · Seminars in Thrombosis and Hemostasis
  182. Calcium channel blockers in heart failure
    Elkayam, Uri · 1998 · Cardiology
  183. The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): Study protocol
    Stefan Hans Hohnloser, Stuart J. Connolly, Karl‐Heinz Kück, Paul Dorian, Eric S. Fain, John Hampton, Róbert Hatala, Andreas C. Pauly, Robin S. Roberts, Ellison Themeles et al. · 2000 · American Heart Journal
  184. The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats
    A. HOLMÄ NG, Naoko Yoshida, Eva Jennische, Anders P. Waldenström, Per A Björntorp · 1996 · European Journal of Clinical Investigation
  185. Aldosterone and heart failure
    Faiez M. Zannad · 1995 · European Heart Journal
  186. Myocardial hypertrophy in the ischemic zone induced by exercise in rats after coronary reperfusion.
    Byung‐Hee Oh, S Ono, Howard A. Rockman, John Ross · 1993 · Circulation
  187. The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure
    A. P. Davie, C. M. Francis, L. Caruana, George Ross Sutherland, John J.V. McMurray · 1997 · European Heart Journal
  188. Contracted plasma and blood volume in chronic heart failure
    Matthew S. Feigenbaum, MICHAEL A. WELSCH, Matthew J Mitchell, Kevin R. Vincent, Randy W. Braith, Carl J. Pepine · 2000 · Journal of the American College of Cardiology
  189. Age-Related Hemodynamic, Renal, and Hormonal Differences Among Patients With Congestive Heart Failure
    Robert J Cody · 1989 · Archives of Internal Medicine
  190. Functional significance of Na- K-ATPase in the kidney: effects of ouabain inhibition
    Jorge Torretti, Ernesto D. Hendler, E Weinstein, Robert E. Longnecker, Epstein Fh · 1972 · American Journal of Physiology-Legacy Content
  191. Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group.
    James Herbert Patterson, Kirkwood F. Adams, Mark M. Applefeld, Clinton N. Corder, Benoît R. Mâsse · 1994 · PubMed
  192. Acetylstrophanthidin-induced reflex inhibition of canine renal sympathetic nerve activity mediated by cardiac receptors with vagal afferents.
    M D Thames · 1979 · Circulation Research
  193. Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure
    Zukaï Chati, Faiez M. Zannad, Claude Jeandel, Brigitte Robin-Lherbier, Jean‐Marie Escanyé, Jacques Robert, Etienne Aliot · 1996 · American Heart Journal
  194. Implantable Left Ventricular Assist Devices
    Joseph John DeRose, Michael Argenziano, Benjamin Sun, K Reemtsma, Mehmet C. Öz, Eric A. Rose · 1997 · Annals of Surgery
  195. The relationship between disorders of K+ and Mg+ homeostasis.
    Richard Solomon · 1987 · PubMed
  196. “Systolic and diastolic dysfunction” in heart failure? Time for a new paradigm
    Marvin A. Konstam · 2003 · Journal of Cardiac Failure
  197. Variations in family physicians’ and cardiologists’ care for patients with heart failure
    David W. Baker, Risa P. Hayes, Barry M. Massie, C Craig · 1999 · American Heart Journal
  198. Enhanced External Counterpulsation in Patients With Heart Failure: A Multicenter Feasibility Study
    Ozlem Z. Soran, Bruce L. Fleishman, Theresa DeMarco, William Grossman, Virginia M. Schneider, Karen S. Manzo, Paul-André de Lame, Arthur Michael Feldman · 2002 · Congestive Heart Failure
  199. An alpha-1-adrenergic receptor subtype is responsible for delayed afterdepolarizations and triggered activity during simulated ischemia and reperfusion of isolated canine Purkinje fibers.
    Victor Molina‐Viamonte, Evgeny P. Anyukhovsky, Michael R. Rosen · 1991 · Circulation
  200. Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects.
    L B Tan, R G Murray, William A. Littler · 1987 · Heart